The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Umbralisib monotherapy demonstrates efficacy and safety in patients with relapsed/refractory marginal zone lymphoma: A multicenter, open label, registration directed phase II study.
 
Nathan Hale Fowler
Consulting or Advisory Role - Bayer; Celgene; Novartis; Roche/Genentech; TG Therapeutics; Verastem
Research Funding - Abbvie; BeiGene; Celgene; Gilead Sciences; Novartis; Roche; TG Therapeutics
 
Felipe Samaniego
Research Funding - ADC Therapeutics
 
Wojciech Jurczak
Consulting or Advisory Role - Acerta Pharma; AstraZeneca; European Medicines Agency; Janssen; Sandoz-Novartis
Research Funding - Acerta Pharma; Afimed; Bayer; BeiGene; Celgene; Epizyme; Gilead Sciences; Janssen; Merck; MorphoSys; Nordic Nanovector; Pharmacyclics; Roche; SERVIER; TG Therapeutics
 
Ewa Lech-Maranda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen-Cilag; Novartis; Roche
 
Nilanjan Ghosh
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Juno Therapeutics; Kite, a Gilead company; Seagen; Spectrum Pharmaceuticals; TG Therapeutics
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Kite/Gilead; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Piers Patten
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Gilead Sciences
Research Funding - Gilead Sciences; Roche
 
James Andrew Reeves
Consulting or Advisory Role - Bayer
Speakers' Bureau - Celgene; Janssen Oncology
 
Lori Ann Leslie
Speakers' Bureau - Celgene; Seagen
 
Julio C. Chavez
No Relationships to Disclose
 
Paolo Ghia
Honoraria - Abbvie; BeiGene; Gilead Sciences; Janssen Oncology; Juno Therapeutics; Roche; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; BeiGene; Gilead Sciences; Janssen; Juno Therapeutics; Sunesis Pharmaceuticals
Speakers' Bureau - Gilead Sciences
Research Funding - Abbvie; Gilead Sciences; Janssen Oncology; Novartis; Sunesis Pharmaceuticals
 
Corrado Tarella
No Relationships to Disclose
 
John M. Burke
Consulting or Advisory Role - Abbvie; Bayer; Celgene; Genentech; Gilead Sciences; Seagen; Tempus
Speakers' Bureau - Seagen
 
Jeff Porter Sharman
Leadership - US Oncology
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Genentech; Pharmacyclics; TG Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
Expert Testimony - Gilead Sciences
 
Kathryn Kolibaba
Employment - Compass Oncology
Honoraria - TG Therapeutics
Consulting or Advisory Role - Gilead Sciences
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Cell Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals
 
Chan Cheah
Honoraria - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Roche; Takeda
Research Funding - Abbvie; Celgene; Roche
Travel, Accommodations, Expenses - Amgen; Roche
 
Hari P. Miskin
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Peter Sportelli
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Michael S. Weiss
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Pier Luigi Zinzani
Honoraria - Bristol-Myers Squibb; Celgene; Celltrion; Gilead Sciences; Janssen; Merck; MSD; Pfizer; Roche; SERVIER; TG Therapeutics; Verastem
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Celltrion; Gilead Sciences; Merck; Pfizer; Roche; SERVIER; Takeda; TG Therapeutics; Verastem
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Celltrion; Gilead Sciences; Janssen; MSD; SERVIER; Verastem